Abstract
Oxidative stress has been documented in tissues and biofluids of subjects with sporadic Alzheimer disease (AD) and mild cognitive impairment (MCI). The aim of this study was to determine whether (a) salivary protein carbonyls are elevated in AD and MCI subjects, (b) salivary protein carbonyl contents in these groups exhibit diurnal variation, and (c) apolipoprotein E ɛ4 (apoE ɛ4) carrier status impacts salivary carbonyl concentrations or rhythmicity in the AD and MCI cohorts. Unstimulated saliva was collected at fixed intervals between 8 AM and 10 PM from 15 AD subject , 21 MCI subjects, and 30 cognitively-intact controls. Salivary protein carbonyl concentrations were measured by ELISA. ApoE genotyping was performed on the AD and MCI individuals. For all groups, mean protein carbonyl contents were significantly elevated at 2 PM relative to other time points surveyed. Mean salivary protein carbonyl concentrations did not differ among the diagnostic groups. ApoE ɛ4 carriers exhibited less temporal variation in salivary protein carbonyls relative to noncarriers. Thus, protein carbonyl content exhibits diurnal variation in adult human saliva. ApoE ɛ4 carrier status may impact oropharyngeal disease expression by attenuating the inherent diurnal variability in salivary redox homeostasis. Salivary protein carbonyls do not differentiate AD and MCI from normal individuals. In conclusion, oxidative stress has been documented in tissues and biofluids of subjects with sporadic AD and MCI. This article demonstrates that levels of protein carbonyls, a marker of oxidative stress, exhibit robust diurnal variation in the saliva of normal elderly, MCI, and AD subjects. Apolipoprotein E ɛ4 allele carrier status may attenuate this temporal variability in salivary redox homeostasis and thereby impact the natural history of oropharyngeal diseases.
Similar content being viewed by others
References
Arana C, Cutando A, Ferrera MJ, Gomez-Moreno G, Worf CV, Bolanos MJ, Escames G, Acuna-Castroviejo D (2006) Parameters of oxidative stress in saliva from diabetic and parenteral drug addict patients. J Oral Pathol Med 35:554–559
Bahar G, Feinmesser R, Shpitzer T, Popovtzer A, Nagler RM (2007) Salivary analysis in oral cancer patients: DNA and protein oxidation, reactive nitrogen species, and antioxidant profile. Cancer 109:54–59
Bennett DA, Wilson RS, Schneider JA, Evans DA, Mendes de Leon CF, Arnold SE, Barnes LL, Bienias JL (2003) Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology 60:1909–1915
Berlin D, Chong G, Chertkow H, Bergman H, Phillips NA, Schipper HM (2004) Evaluation of HFE (hemochromatosis) mutations as genetic modifiers in sporadic AD and MCI. Neurobiol Aging 25:465–474
Biswas SK, Newby DE, Rahman I, Megson IL (2005) Depressed glutathione synthesis precedes oxidative stress and atherogenesis in Apo-E(−/−) mice. Biochem Biophys Res Commun 338:1368–1373
Bridges AB, Fisher TC, Scott N, McLaren M, Belch JJ (1992a) Circadian rhythm of white blood cell aggregation and free radical status in healthy volunteers. Free Radic Res Commun 16:89–97
Bridges AB, Scott NA, McNeill GP, Pringle TH, Belch JJ (1992b) Circadian variation of white blood cell aggregation and free radical indices in men with ischaemic heart disease. Eur Heart J 13:1632–1636
Buss H, Chan TP, Sluis KB, Domigan NM, Winterbourn CC (1997) Protein carbonyl measurement by a sensitive ELISA method. Free Radic Biol Med 23:361–366
Celec P, Hodosy J, Celecova V, Vodrazka J, Cervenka T, Halcak L, Bozek P, Kopani M, Kudela M (2005) Salivary thiobarbituric acid reacting substances and malondialdehyde—their relationship to reported smoking and to parodontal status described by the papillary bleeding index. Dis Markers 21:133–137
Chan A, Shea TB (2006) Dietary and genetically-induced oxidative stress alter tau phosphorylation: influence of folate and apolipoprotein E deficiency. J Alzheimers Dis 9:399–405
Chertkow H, Bergman H, Schipper HM, Gauthier S, Bouchard R, Fontaine S, Clarfield AM (2001) Assessment of suspected dementia. Can J Neurol Sci 28(suppl 1):S28–S41
Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261:921–923
Den R, Toda M, Nagasawa S, Kitamura K, Morimoto K (2007) Circadian rhythm of human salivary chromogranin A. Biomed Res 28:57–60
Fagan AM, Holtzman DM (2000) Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo. Microsc Res Tech 50:297–304
Fiocco AJ, Wan N, Weekes N, Pim H, Lupien SJ (2006) Diurnal cycle of salivary cortisol in older adult men and women with subjective complaints of memory deficits and/or depressive symptoms: relation to cognitive functioning. Stress 9:143–152
Folkmann JK, Loft S, Moller P (2007) Oxidatively damaged DNA in aging dyslipidemic ApoE−/− and wild-type mice. Mutagenesis 22:105–110
Giubilei F, Patacchioli FR, Antonini G, Sepe Monti M, Tisei P, Bastianello S, Monnazzi P, Angelucci L (2001) Altered circadian cortisol secretion in Alzheimer’s disease: clinical and neuroradiological aspects. J Neurosci Res 66:262–265
Gorelik S, Kohen R, Ligumsky M, Kanner J (2007) Saliva plays a dual role in oxidation process in stomach medium. Arch Biochem Biophys 458:236–243
Hardeland R, Coto-Montes A, Poeggeler B (2003) Circadian rhythms, oxidative stress, and antioxidative defense mechanisms. Chronobiol Int 20:921–962
Hatfield CF, Herbert J, van Someren EJ, Hodges JR, Hastings MH (2004) Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer’s dementia. Brain 127:1061–1074
Hensley K, Hall N, Subramaniam R, Cole P, Harris M, Aksenov M, Aksenova M, Gabbita SP, Wu JF, Carney JM et al (1995) Brain regional correspondence between Alzheimer’s disease histopathology and biomarkers of protein oxidation. J Neurochem 65:2146–2156
Hershkovich O, Shafat I, Nagler RM (2007) Age-related changes in salivary antioxidant profile: possible implications for oral cancer. J Gerontol A Biol Sci Med Sci 62:361–366
Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545–548
Huang Y, Weisgraber KH, Mucke L, Mahley RW (2004) Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer’s disease. J Mol Neurosci 23:189–204
Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566–572
Ice GH, Katz-Stein A, Himes J, Kane RL (2004) Diurnal cycles of salivary cortisol in older adults. Psychoneuroendocrinology 29:355–370
Jahanshahi G, Motavasel V, Rezaie A, Hashtroudi AA, Daryani NE, Abdollahi M (2004) Alterations in antioxidant power and levels of epidermal growth factor and nitric oxide in saliva of patients with inflammatory bowel diseases. Dig Dis Sci 49:1752–1757
Jofre-Monseny L, Loboda A, Wagner AE, Huebbe P, Boesch-Saadatmandi C, Jozkowicz A, Minihane AM, Dulak J, Rimbach G (2007) Effects of apoE genotype on macrophage inflammation and heme oxygenase-1 expression. Biochem Biophys Res Commun 357:319–324
Kanabrocki EL, Third JL, Ryan MD, Nemchausky BA, Shirazi P, Scheving LE, McCormick JB, Hermida RC, Bremner WF, Hoppensteadt DA, Fareed J, Olwin JH (2000) Circadian relationship of serum uric acid and nitric oxide. JAMA 283:2240–2241
Kanabrocki EL, Murray D, Hermida RC, Scott GS, Bremner WF, Ryan MD, Ayala DE, Third JL, Shirazi P, Nemchausky BA, Hooper DC (2002) Circadian variation in oxidative stress markers in healthy and type II diabetic men. Chronobiol Int 19:423–439
Kanabrocki EL, Ryan MD, Hermida RC, Ayala DE, Scott GS, Murray D, Bremner WF, Third JL, Johnson MC, Foley S, Van Cauteren J, Shah F, Shirazi P, Nemchausky BA, Hooper DC (2004) Altered circadian relationship between serum nitric oxide, carbon dioxide, and uric acid in multiple sclerosis. Chronobiol Int 21:739–758
Kaufman E, Lamster IB (2002) The diagnostic applications of saliva-a review. Crit Rev Oral Biol Med 13:197–212
Kolarzyk E, Pietrzycka A, Stepniewski M, Lyszczarz J, Mendyk A, Ostachowska-Gasior A (2006) Micronutrients and macronutrients and parameters of antioxidative ability in saliva of women: inhabitants of Krakow (Poland) in the course of uncomplicated singleton pregnancy. Biol Trace Elem Res 114:73–84
Levy R (1994) Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr 6:63–68
Luo H, Guo H, Xiao J, Xue Z (1997) Circadian variations of plasma SOD and MDA in health subjects. Hua Xi Yi Ke Da Xue Xue Bao 28:401–403
Maes OC, Kravitz S, Mawal Y, Su H, Liberman A, Mehindate K, Berlin D, Sahlas DJ, Chertkow HM, Bergman H, Melmed C, Schipper HM (2006a) Characterization of alpha1-antitrypsin as a heme oxygenase-1 suppressor in Alzheimer plasma. Neurobiol Dis 24:89–100
Maes OC, Xu S, Yu B, Chertkow HM, Wang E, Schipper HM (2006b) Transcriptional profiling of Alzheimer blood mononuclear cells by microarray. Neurobiol Aging 28:1795–1809
Mashayekhi F, Aghahoseini F, Rezaie A, Zamani MJ, Khorasani R, Abdollahi M (2005) Alteration of cyclic nucleotides levels and oxidative stress in saliva of human subjects with periodontitis. J Contemp Dent Pract 6:46–53
Mazur-Kolecka B, Dickson D, Frackowiak J (2006) Induction of vascular amyloidosis-beta by oxidative stress depends on APOE genotype. Neurobiol Aging 27:804–814
Nagler R, Lischinsky S, Diamond E, Drigues N, Klein I, Reznick AZ (2000) Effect of cigarette smoke on salivary proteins and enzyme activities. Arch Biochem Biophys 379:229–236
Niklowitz P, Andler W, Menke T (2006) Coenzyme Q10 concentration in plasma and blood cells: what about diurnal changes? Biofactors 28:47–54
Pavlik VN, Doody RS, Massman PJ, Chan W (2006) Influence of premorbid IQ and education on progression of Alzheimer’s disease. Dement Geriatr Cogn Disord 22:367–377
Porter RJ, Marshall EF, O’Brien JT (2002) Effects of rapid tryptophan depletion on salivary and plasma cortisol in Alzheimer’s disease and the healthy elderly. J Psychopharmacol 16:73–78
Reiter RJ, Barlow-Walden L, Poeggeler B, Heiden SM, Clayton RJ (1996) Twenty-four hour urinary excretion of 6-hydroxymelatonin sulfate in Down syndrome subjects. J Pineal Res 20:45–50
Reznick AZ, Shehadeh N, Shafir Y, Nagler RM (2006) Free radicals related effects and antioxidants in saliva and serum of adolescents with Type 1 diabetes mellitus. Arch Oral Biol 51:640–648
Ryo K, Yamada H, Nakagawa Y, Tai Y, Obara K, Inoue H, Mishima K, Saito I (2006) Possible involvement of oxidative stress in salivary gland of patients with Sjogren’s syndrome. Pathobiology 73:252–260
Sawamoto Y, Sugano N, Tanaka H, Ito K (2005) Detection of periodontopathic bacteria and an oxidative stress marker in saliva from periodontitis patients. Oral Microbiol Immunol 20:216–220
Sayer R, Law E, Connelly PJ, Breen KC (2004) Association of a salivary acetylcholinesterase with Alzheimer’s disease and response to cholinesterase inhibitors. Clin Biochem 37:98–104
Scherder E, Knol D, van Tol MJ, van Someren E, Deijen JB, Swaab D, Scheltens P (2006) Effects of high-frequency cranial electrostimulation on the rest-activity rhythm and salivary cortisol in Alzheimer’s disease: a pilot study. Dement Geriatr Cogn Disord 22:267–272
Schipper HM (2007) The role of biological markers in the diagnosis of Alzheimer’s disease. Alzheimer’s Dement 3:325–332
Schipper HM, Chertkow H, Mehindate K, Frankel D, Melmed C, Bergman H (2000) Evaluation of heme oxygenase-1 as a systemic biological marker of sporadic AD. Neurology 54:1297–1304
Schipper HM, Bennett DA, Liberman A, Bienias JL, Schneider JA, Kelly J, Arvanitakis Z (2006) Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging 27:252–261
Sculley DV, Langley-Evans SC (2003) Periodontal disease is associated with lower antioxidant capacity in whole saliva and evidence of increased protein oxidation. Clin Sci (Lond) 105:167–172
Selkoe DJ (1991) The molecular pathology of Alzheimer’s disease. Neuron 6:487–498
Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci USA 88:10540–10543
Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N (1996) Oxidative damage in Alzheimer’s. Nature 382:120–121
Song W, Su H, Song S, Paudel HK, Schipper HM (2006) Over-expression of heme oxygenase-1 promotes oxidative mitochondrial damage in rat astroglia. J Cell Physiol 206:655–663
Sramek JJ, Cutler NR, Hurley DJ, Seifert RD (1995) The utility of salivary amylase as an evaluation of M3 muscarinic agonist activity in Alzheimer’s disease. Prog Neuropsychopharmacol Biol Psychiatry 19:85–91
Sugano N, Yokoyama K, Oshikawa M, Kumagai K, Takane M, Tanaka H, Ito K (2003) Detection of Streptococcus anginosus and 8-hydroxydeoxyguanosine in saliva. J Oral Sci 45:181–184
Takane M, Sugano N, Iwasaki H, Iwano Y, Shimizu N, Ito K (2002) New biomarker evidence of oxidative DNA damage in whole saliva from clinically healthy and periodontally diseased individuals. J Periodontol 73:551–554
Tsai CC, Chen HS, Chen SL, Ho YP, Ho KY, Wu YM, Hung CC (2005) Lipid peroxidation: a possible role in the induction and progression of chronic periodontitis. J Periodontal Res 40:378–384
Valencia E, Marin A, Hardy G (2001) Circadian rhythmicity of whole-blood glutathione in healthy subjects. Nutrition 17:731–733
Winterbourn CC, Buss IH (1999) Protein carbonyl measurement by enzyme-linked immunosorbent assay. Methods Enzymol 300:106–111
Wolf OT, Convit A, Thorn E, de Leon MJ (2002) Salivary cortisol day profiles in elderly with mild cognitive impairment. Psychoneuroendocrinology 27:777–789
Woods DL, Dimond M (2002) The effect of therapeutic touch on agitated behavior and cortisol in persons with Alzheimer’s disease. Biol Res Nurs 4:104–114
Zloczower M, Reznick AZ, Zouby RO, Nagler RM (2007) Relationship of flow rate, uric acid, peroxidase, and superoxide dismutase activity levels with complications in diabetic patients: can saliva be used to diagnose diabetes? Antioxid Redox Signal 9:765–773
Acknowledgments
This study was supported by grants from the Canadian Institutes of Health Research and internal JGH funds (to HMS).
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Su, H., Gornitsky, M., Geng, G. et al. Diurnal variations in salivary protein carbonyl levels in normal and cognitively impaired human subjects. AGE 30, 1–9 (2008). https://doi.org/10.1007/s11357-007-9042-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11357-007-9042-z